Literature DB >> 35446119

Interbacterial Antagonism Mediated by a Released Polysaccharide.

Yiwei Liu1,2, Erin S Gloag2, Preston J Hill2, Matthew R Parsek3, Daniel J Wozniak1,2.   

Abstract

Pseudomonas aeruginosa and Staphylococcus aureus are two common pathogens causing chronic infections in the lungs of people with cystic fibrosis (CF) and in wounds, suggesting that these two organisms coexist in vivo. However, P. aeruginosa utilizes various mechanisms to antagonize S. aureus when these organisms are grown together in vitro. Here, we suggest a novel role for Psl in antagonizing S. aureus growth. Psl is an exopolysaccharide that exists in both cell-associated and cell-free forms and is important for biofilm formation in P. aeruginosa. When grown in planktonic coculture with a P. aeruginosa psl mutant, S. aureus had increased survival compared to when it was grown with wild-type P. aeruginosa. We found that cell-free Psl was critical for the killing, as purified cell-free Psl was sufficient to kill S. aureus. Transmission electron microscopy of S. aureus treated with Psl revealed disrupted cell envelopes, suggesting that Psl causes S. aureus cell lysis. This was independent of known mechanisms used by P. aeruginosa to antagonize S. aureus. Cell-free Psl could also promote S. aureus killing during growth in in vivo-like conditions. We also found that Psl production in P. aeruginosa CF clinical isolates positively correlated with the ability to kill S. aureus. This could be a result of P. aeruginosa coevolution with S. aureus in CF lungs. In conclusion, this study defines a novel role for P. aeruginosa Psl in killing S. aureus, potentially impacting the coexistence of these two opportunistic pathogens in vivo. IMPORTANCE Pseudomonas aeruginosa and Staphylococcus aureus are two important opportunistic human pathogens commonly coisolated from clinical samples. However, P. aeruginosa can utilize various mechanisms to antagonize S. aureus in vitro. Here, we investigated the interactions between these two organisms and report a novel role for P. aeruginosa exopolysaccharide Psl in killing S. aureus. We found that cell-free Psl could kill S. aureus in vitro, possibly by inducing cell lysis. This was also observed in conditions reflective of in vivo scenarios. In accord with this, Psl production in P. aeruginosa clinical isolates positively correlated with their ability to kill S. aureus. Together, our data suggest a role for Psl in affecting the coexistence of P. aeruginosa and S. aureus in vivo.

Entities:  

Keywords:  Pseudomonas aeruginosa; Psl; Staphylococcus aureus; cell lysis; cystic fibrosis; exopolysaccharide; polymicrobial; wound

Mesh:

Substances:

Year:  2022        PMID: 35446119      PMCID: PMC9112932          DOI: 10.1128/jb.00076-22

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.476


  59 in total

1.  Structural investigation of a polysaccharide from the mycelium of Enterobacter cloacae and its antibacterial activity against extensively drug-resistant E. cloacae producing SHV-12 extended-spectrum β-lactamase.

Authors:  Jun Liu; Zhujin Xu; Zhen Guo; Zuguo Zhao; Yi Zhao; Xin Wang
Journal:  Carbohydr Polym       Date:  2018-04-30       Impact factor: 9.381

2.  Analysis of Pseudomonas aeruginosa conditional psl variants reveals roles for the psl polysaccharide in adhesion and maintaining biofilm structure postattachment.

Authors:  Luyan Ma; Kara D Jackson; Rebecca M Landry; Matthew R Parsek; Daniel J Wozniak
Journal:  J Bacteriol       Date:  2006-09-15       Impact factor: 3.490

3.  Essential genome of Pseudomonas aeruginosa in cystic fibrosis sputum.

Authors:  Keith H Turner; Aimee K Wessel; Gregory C Palmer; Justine L Murray; Marvin Whiteley
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-16       Impact factor: 11.205

4.  Investigation of the algT operon sequence in mucoid and non-mucoid Pseudomonas aeruginosa isolates from 115 Scandinavian patients with cystic fibrosis and in 88 in vitro non-mucoid revertants.

Authors:  Oana Ciofu; Baoleri Lee; Marie Johannesson; Nils Olav Hermansen; Peter Meyer; Niels Høiby
Journal:  Microbiology       Date:  2008-01       Impact factor: 2.777

Review 5.  Treatment of lung infection in patients with cystic fibrosis: current and future strategies.

Authors:  Gerd Döring; Patrick Flume; Harry Heijerman; J Stuart Elborn
Journal:  J Cyst Fibros       Date:  2012-11-06       Impact factor: 5.482

6.  Identification of broadly protective human antibodies to Pseudomonas aeruginosa exopolysaccharide Psl by phenotypic screening.

Authors:  Antonio DiGiandomenico; Paul Warrener; Melissa Hamilton; Sandrine Guillard; Peter Ravn; Ralph Minter; Maria Margarita Camara; Vignesh Venkatraman; Randall S Macgill; Jia Lin; Qun Wang; Ashley Elaine Keller; Jessica C Bonnell; Mladen Tomich; Lutz Jermutus; Michael P McCarthy; David A Melnick; Joann A Suzich; C Kendall Stover
Journal:  J Exp Med       Date:  2012-06-25       Impact factor: 14.307

7.  Phenotypes of non-attached Pseudomonas aeruginosa aggregates resemble surface attached biofilm.

Authors:  Morten Alhede; Kasper Nørskov Kragh; Klaus Qvortrup; Marie Allesen-Holm; Maria van Gennip; Louise D Christensen; Peter Østrup Jensen; Anne K Nielsen; Matt Parsek; Dan Wozniak; Søren Molin; Tim Tolker-Nielsen; Niels Høiby; Michael Givskov; Thomas Bjarnsholt
Journal:  PLoS One       Date:  2011-11-21       Impact factor: 3.240

8.  An improved method for rapid generation of unmarked Pseudomonas aeruginosa deletion mutants.

Authors:  Kyoung-Hee Choi; Herbert P Schweizer
Journal:  BMC Microbiol       Date:  2005-05-23       Impact factor: 3.605

9.  A Pseudomonas aeruginosa Antimicrobial Affects the Biogeography but Not Fitness of Staphylococcus aureus during Coculture.

Authors:  Juan P Barraza; Marvin Whiteley
Journal:  mBio       Date:  2021-03-30       Impact factor: 7.867

10.  Staphylococcus aureus Protein A Mediates Interspecies Interactions at the Cell Surface of Pseudomonas aeruginosa.

Authors:  Catherine R Armbruster; Daniel J Wolter; Meenu Mishra; Hillary S Hayden; Matthew C Radey; Gennifer Merrihew; Michael J MacCoss; Jane Burns; Daniel J Wozniak; Matthew R Parsek; Lucas R Hoffman
Journal:  mBio       Date:  2016-05-24       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.